The ZFYVE27 Gene SPG33 Genetic Test is a specialized diagnostic procedure aimed at identifying mutations in the ZFYVE27 gene, which are linked to the development of spastic paraplegia 33 (SPG33), a rare form of hereditary spastic paraplegia. This condition is characterized by progressive stiffness and contraction in the lower limbs, affecting mobility and daily activities. The test involves analyzing the patient's DNA to detect any genetic anomalies associated with SPG33, providing crucial information for diagnosis, management, and family planning.
Conducted at DNA Labs UAE, a leading facility in genetic testing, this test is available for a cost of 4400 AED. DNA Labs UAE employs state-of-the-art technology and highly qualified professionals to ensure accurate and reliable results. By opting for the ZFYVE27 Gene SPG33 Genetic Test, patients and their families can gain valuable insights into their genetic health, paving the way for tailored treatment plans and informed decisions about their future.
The FA2H gene SPG35 genetic test is a specialized diagnostic procedure aimed at detecting mutations in the FA2H gene, which are associated with a rare form of hereditary spastic paraplegia (HSP), known as SPG35. This condition is characterized by progressive weakness and stiffness of the legs, and in some cases, it may also affect the arms and other parts of the body. The genetic test is crucial for accurate diagnosis, enabling targeted management and genetic counseling for affected individuals and their families.
Conducted at DNA Labs UAE, a reputable facility known for its advanced genetic testing capabilities, the FA2H gene SPG35 genetic test involves analyzing the patient's DNA to identify mutations in the FA2H gene. This gene plays a significant role in the metabolism of certain fats in the brain and nervous system, and mutations can lead to the neurological symptoms observed in SPG35.
The cost of the FA2H gene SPG35 genetic test at DNA Labs UAE is set at 4400 AED. This price reflects the sophisticated nature of the testing process, including the extraction of DNA, the use of advanced sequencing technologies to scrutinize the FA2H gene, and the expert analysis required to interpret the results accurately. While the cost may seem high, the test offers invaluable insights for affected individuals, guiding treatment options and helping families understand the risk of inheritance.
The PNPLA6 gene SPG39 genetic test is a specialized diagnostic procedure aimed at identifying mutations in the PNPLA6 gene, which are associated with spastic paraplegia 39 (SPG39). This condition is a form of hereditary spastic paraplegia, characterized by progressive weakness and stiffness of the legs. The test is crucial for individuals showing symptoms of SPG39 or those with a family history of the condition, as it aids in confirming the diagnosis, understanding the disease progression, and making informed decisions regarding management and treatment.
Performed at DNA Labs UAE, a leading facility in genetic diagnostics, the test involves analyzing the patient's DNA sample to detect any genetic abnormalities present in the PNPLA6 gene. The process is conducted with high precision and accuracy, ensuring reliable results for patients and healthcare providers.
The cost of the PNPLA6 gene SPG39 genetic test at DNA Labs UAE is set at 4400 AED. This price reflects the comprehensive nature of the test, including the sophisticated technology and expertise required to accurately identify mutations in the PNPLA6 gene. Patients seeking this test can expect a seamless and supportive experience, with guidance from skilled professionals throughout the testing process.
The ATL1 gene SPG3A genetic test is a specialized diagnostic tool designed to identify mutations in the ATL1 gene, which are known to cause a form of hereditary spastic paraplegia (HSP) known as SPG3A. This condition is characterized by progressive stiffness and weakness in the legs due to the degeneration of nerve pathways responsible for movement control. Early detection through genetic testing can be crucial for managing symptoms, planning treatment strategies, and understanding the risk of passing the condition to future generations.
DNA Labs UAE offers this specific genetic test, providing a comprehensive analysis of the ATL1 gene to identify any mutations associated with SPG3A. The test is priced at 4400 AED and is conducted in a state-of-the-art laboratory facility, ensuring high accuracy and reliability of the results. Individuals who have a family history of HSP or exhibit symptoms related to the condition may consider undergoing this test for a clear diagnosis. The results can also offer valuable insights for families planning children and looking to assess genetic risks.
The SPAST gene SPG4 genetic test is a specialized diagnostic tool designed to identify mutations in the SPAST gene, which is primarily associated with Spastic Paraplegia 4 (SPG4). SPG4, also known as Hereditary Spastic Paraplegia 4, is a neurological disorder characterized by progressive weakness and stiffness of the legs. The SPAST gene plays a crucial role in the development and maintenance of the nervous system, and mutations in this gene are the most common cause of autosomal dominant hereditary spastic paraplegia.
Conducted at DNA Labs UAE, this genetic test involves analyzing the patient's DNA to detect any abnormalities or mutations in the SPAST gene that may lead to the condition. Early diagnosis through genetic testing can be vital for the management and treatment of SPG4, allowing for personalized treatment plans and genetic counseling for affected individuals and their families.
The cost of the SPAST gene SPG4 genetic test at DNA Labs UAE is 4400 AED. This price may cover the collection of the sample, the genetic analysis, and the provision of a detailed report by healthcare professionals. It's important for patients considering this test to consult with their healthcare provider to understand the implications of the results and the next steps in the case of a positive finding.
The SLC33A1 gene, associated with SPG42 (Spastic Paraplegia 42), is crucial for understanding and managing this rare hereditary disorder. SPG42 is characterized by progressive weakness and stiffness of the legs, resulting from the degeneration of nerve cells that control muscle movement and coordination. The genetic test for SPG42, focusing on the SLC33A1 gene, is an essential diagnostic tool for individuals showing symptoms of this condition or those with a family history of hereditary spastic paraplegia.
Conducted at DNA Labs UAE, the test for the SLC33A1 gene associated with SPG42 involves analyzing the patient's DNA to identify mutations in the SLC33A1 gene that could lead to the disorder. This precise genetic testing can confirm a diagnosis of SPG42, allowing for appropriate management and treatment plans to be developed. It can also provide valuable information for family planning and genetic counseling for affected families.
The cost of the SLC33A1 gene SPG42 genetic test at DNA Labs UAE is 4400 AED. This investment covers the comprehensive analysis required to detect the specific genetic alterations within the SLC33A1 gene that are responsible for SPG42. By opting for this test, patients and their families can gain insights into the genetic basis of the condition, enabling informed decisions about care and support.
The C19orf12 gene, associated with the condition known as Spastic Paraplegia 43 (SPG43), is a critical genetic marker for diagnosing this rare hereditary spastic paraplegia. The SPG43 genetic test specifically targets mutations within the C19orf12 gene to confirm the diagnosis, allowing for appropriate management and genetic counseling. DNA Labs UAE offers this specialized genetic test for individuals suspected of having SPG43. The test is priced at 4400 AED, reflecting the advanced molecular techniques employed to accurately identify mutations in the C19orf12 gene. This test is crucial for families seeking answers to genetic conditions, providing them with the necessary information to understand their genetic health better.
The GJC2 Gene SPG44 Genetic Test is a specialized diagnostic procedure aimed at identifying mutations in the GJC2 gene, which are associated with Spastic Paraplegia 44 (SPG44), a rare form of hereditary spastic paraplegia. This condition is characterized by progressive weakness and spasticity, primarily in the lower limbs, and can lead to severe mobility issues. The test involves analyzing the patient's DNA to detect specific genetic alterations in the GJC2 gene that are known to cause SPG44.
Performed at DNA Labs UAE, a leading facility in genetic testing, this test is crucial for individuals with a family history of hereditary spastic paraplegia or those exhibiting symptoms, providing them with a definitive diagnosis. Early detection through this genetic test can significantly aid in managing the condition, allowing for appropriate therapeutic interventions and genetic counseling for affected families.
The cost of the GJC2 Gene SPG44 Genetic Test at DNA Labs UAE is 4400 AED, reflecting the comprehensive analysis and detailed insights it provides into the patient's genetic makeup regarding SPG44. This investment in health can be invaluable for affected individuals and their families, offering clarity on the condition and guidance on how to best manage it.
The NT5C2 Gene SPG45 Genetic Test is a specialized diagnostic tool designed to identify mutations in the NT5C2 gene, which are associated with Spastic Paraplegia 45 (SPG45), a rare form of hereditary spastic paraplegia. This condition is characterized by progressive stiffness and contraction in the lower limbs, leading to mobility challenges and other neurological symptoms. By analyzing the patient's DNA, this test can confirm the presence of genetic alterations in the NT5C2 gene, providing crucial information for accurate diagnosis, management, and genetic counseling of affected individuals and their families.
The test is conducted at DNA Labs UAE, a leading facility in genetic diagnostics that employs cutting-edge technology and methodologies to ensure high accuracy and reliability of results. The cost of the NT5C2 Gene SPG45 Genetic Test is 4400 AED, reflecting the specialized nature of the analysis and the comprehensive insights it offers into the patient's genetic makeup. This information is invaluable for devising personalized treatment plans and understanding the inheritance patterns, potentially benefiting other family members.
The KCNQ3 Gene Seizures Benign Neonatal Type 2 Genetic Test is a specialized diagnostic tool offered by DNA Labs UAE, designed to identify mutations in the KCNQ3 gene, which are associated with Benign Neonatal Seizures Type 2 (BNST2). This condition is characterized by the onset of seizures within the first days or weeks of life, which usually resolve spontaneously within the first year. Although the seizures are generally not harmful to the infant's long-term development, early and accurate diagnosis is crucial for appropriate management and to alleviate parental concerns.
The test involves analyzing the patient's DNA to detect any genetic alterations in the KCNQ3 gene, which plays a critical role in the proper functioning of nerve cells in the brain. Mutations in this gene can disrupt the normal flow of potassium ions in neurons, leading to the development of seizures.
Priced at 4400 AED, the test is conducted at DNA Labs UAE, a facility known for its advanced genetic testing capabilities and high standards of accuracy and reliability. This test is particularly valuable for families with a history of BNST2, as it can provide essential information for early intervention strategies and help in understanding the genetic predisposition to the condition within the family.
